These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 1094102

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L, Boeri S, Ricci G.
    Minerva Cardioangiol; 1974 Apr; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract] [Full Text] [Related]

  • 5. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
    Parodi FA, Caputo G.
    Clin Ter; 1976 Dec 31; 79(6):571-81. PubMed ID: 1009761
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S.
    G Clin Med; 1974 Jan 31; 55(1):27-39. PubMed ID: 4369524
    [No Abstract] [Full Text] [Related]

  • 11. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
    Fisanovich TI, Tolstova LG.
    Khirurgiia (Mosk); 1979 Sep 31; (9):76-80. PubMed ID: 502312
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and laboratory examinations with Prodectin.
    Bédi J, Kosztovics A, Pálos LA.
    Ther Hung; 1976 Sep 31; 24(3):91-7. PubMed ID: 1013926
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
    Roztocil K, Oliva I, Linhart J, Prerovský I, Modr Z.
    Cas Lek Cesk; 1976 Aug 27; 115(33-34):1051-5. PubMed ID: 975177
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Value of pyridinol carbamate in ocular vascular pathology (Angioxine)].
    Boudet, Millet, Arnaud.
    Bull Soc Ophtalmol Fr; 1974 Aug 27; 74(9-10):977-80. PubMed ID: 4470033
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of chronic ischemic cardiopathy with a combination of pyridinolcarbamate and clofibrate].
    Guerrera G, Melina D.
    Clin Ter; 1980 Mar 15; 92(5):533-47. PubMed ID: 7449327
    [No Abstract] [Full Text] [Related]

  • 20. A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion.
    Mishima Y, Kamiya K, Sakaguchi S, Kusaba A, Sakuma A.
    Angiology; 1977 Feb 15; 28(2):84-94. PubMed ID: 326097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.